FDA approves Bayer’s Finerenone for new indication in patients with HF and LVEF of ?40%
Finerenone significantly reduced the combined risk of cardiovascular death and total (first and recurrent) heart failure events,
Finerenone significantly reduced the combined risk of cardiovascular death and total (first and recurrent) heart failure events,
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
Baxdrostat demonstrated a statistically significant and clinically meaningful reduction of systolic blood pressure compared with placebo
The company’s largest center for medical device applications, serving the entire Asian market
This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
IGI partners with AbbVie and grants exclusive rights to globally develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
He has held senior leadership positions at Syngene International, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, Sartorius Stedim Biotech, and other leading organizations
Addresses brain metastases harboring BRCA1/2 and/or HRR alterations—an area of high unmet need
Subscribe To Our Newsletter & Stay Updated